MiraeING.Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 12, 2021 at 12:15 am EST
Share
MiraeING.Co.,Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was KRW 1,619.59 million compared to KRW 1,309.07 million a year ago. Net loss was KRW 366.96 million compared to net income of KRW 288.71 million a year ago. Basic loss per share from continuing operations was KRW 3 compared to basic earnings per share from continuing operations of KRW 3 a year ago. Diluted loss per share from continuing operations was KRW 3 compared to diluted earnings per share from continuing operations of KRW 3 a year ago. Basic loss per share was KRW 3 compared to basic earnings per share of KRW 3 a year ago.
For the nine months, sales was KRW 5,866.88 million compared to KRW 3,981.57 million a year ago. Net income was KRW 1,852.26 million compared to KRW 19,250.21 million a year ago. Basic earnings per share from continuing operations was KRW 6 compared to KRW 151 a year ago. Diluted earnings per share from continuing operations was KRW 6 compared to KRW 151 a year ago. Basic earnings per share was KRW 15 compared to KRW 150 a year ago.
MiraeING.Co.,Ltd., formerly Theall Medi Bio. Co.,Ltd., is a Korea-based company mainly engaged in solution business and video business. The Company operates in three main segments: solution segment, which provides project consulting, construction and maintenance services and related products for banks under the brand name XiT, eNisis and others; video segment, which provides digital video recorders (DVRs) and closed circuit television (CCTV) systems for security areas, and defense segment, which provides self-propelled artilleries and components. It also engages in the leasing of non-residential buildings.
MIRAEING.CO.,LTD. 
